中国实用内科杂志2025，Vol.45Issue(8)：629-632,4.DOI:10.19538/j.nk2025080101
是否可以依据骨转换标志物选择抗骨质疏松药物?
Can anti-osteoporosis drugs be selected based on bone turnover markers?
摘要
Abstract
Choosing appropriate anti-osteoporosis drugs can reduce the risk of fractures and achieve treatment goals.This article focuses on a hot topic in our clinical practice,whether clinical physicians can choose bone resorption inhibitors or bone formation promoters on the level of bone turnover biochemical markers in the management of primary osteoporosis?This article provides a review on important guidelines or relevant research results at home and abroad.关键词
骨质疏松症/骨转换标志物/药物选择Key words
osteoporosis/bone turnover markers/drug selection分类
医药卫生引用本文复制引用
章振林..是否可以依据骨转换标志物选择抗骨质疏松药物?[J].中国实用内科杂志,2025,45(8):629-632,4.基金项目
国家自然科学基金(8257032176) （8257032176）
